Full Text View
Tabular View
No Study Results Posted
Related Studies
Vascular Access Clinical Trials Data Coordinating Center
This study has been completed.
Study NCT00067119   Information provided by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

First Received on August 11, 2003.   Last Updated on March 2, 2010   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Kidney Failure
Additional conditions recognized in this trial
Renal Insufficiency
More general conditions related to this trial
Kidney Diseases
Urologic Diseases
Interventions listed in this trial
Aggrenox
Clopidogrel
Additional drug interventions recognized in this trial
Aspirin, dipyridamole drug combination
More general drug interventions related to this trial
Hematologic Agents
Molecular Mechanisms of Pharmacological Action
Neurotransmitter Agents
Pharmacologic Actions
Physiological Effects of Drugs
Platelet Aggregation Inhibitors
Purinergic Agents
Purinergic Antagonists
Purinergic P2 Receptor Antagonists
Purinergic P2Y Receptor Antagonists
Therapeutic Uses
Sponsors listed in this trial
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
The Cleveland Clinic
Boston University
Duke University
University of Iowa
Maine Medical Center
University of Texas Southwestern Medical Center
University of Alabama at Birmingham
Washington University School of Medicine
Baystate Medical Center
Vanderbilt University
CAMC Health System
Emory University
St. Louis University
Tyler Nephrology Associates
Vascular Surgery Associates LLC


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services